These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis. Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367 [TBL] [Abstract][Full Text] [Related]
8. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain. Brown SA; Cheng E; Williams MS; Winkles JA PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247 [TBL] [Abstract][Full Text] [Related]
9. The TWEAK-Fn14 system as a potential drug target. Wajant H Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828 [TBL] [Abstract][Full Text] [Related]
10. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561 [TBL] [Abstract][Full Text] [Related]
11. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14). Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603 [TBL] [Abstract][Full Text] [Related]
12. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system. Echeverry R; Wu F; Haile WB; Wu J; Yepes M J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384 [TBL] [Abstract][Full Text] [Related]
13. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571 [TBL] [Abstract][Full Text] [Related]
14. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways. Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440 [TBL] [Abstract][Full Text] [Related]
15. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock. Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818 [TBL] [Abstract][Full Text] [Related]
16. TWEAK/Fn14 signaling in tumors. Hu G; Zeng W; Xia Y Tumour Biol; 2017 Jun; 39(6):1010428317714624. PubMed ID: 28639899 [TBL] [Abstract][Full Text] [Related]
17. Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases. Zhu LX; Zhang HH; Mei YF; Zhao YP; Zhang ZY Chin Med J (Engl); 2012 Nov; 125(21):3898-904. PubMed ID: 23106895 [TBL] [Abstract][Full Text] [Related]
18. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization. Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972 [TBL] [Abstract][Full Text] [Related]
19. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor. Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080 [TBL] [Abstract][Full Text] [Related]
20. TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus. Liu Y; Xu M; Min X; Wu K; Zhang T; Li K; Xiao S; Xia Y Front Immunol; 2017; 8():651. PubMed ID: 28620393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]